EverSource Wealth Advisors »

Lineage Cell Therapeutics In shares owned by EverSource Wealth Advisors

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by EverSource Wealth Advisors from 13F filings

Historical chart of EverSource Wealth Advisors investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by EverSource Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by EverSource Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $487 288 1.69
2025-06-30 $909 1.0k 0.91
2025-03-31 $50 111 0.45

More positions owned by EverSource Wealth Advisors

Vanguard Growth Etf Etf (VUG)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Value Etf Etf (VTV)
iShares Gold Trust ETF Etf (IAU)
Apple Stock (AAPL)
Nvidia Corporation Stock (NVDA)
Fidelity Wise Origin Bitcoin Fund Etf (FBTC)
Praxis Impact Large Cap Growth Etf Etf (PRXG)
Praxis Impact Large Cap Value Etf Etf (PRXV)
Microsoft Corp Stock (MSFT)
Tesla Stock (TSLA)
Spdr Bloomberg 1-3 Month T-bill Etf Etf (BIL)
Vanguard Total Stock Market Etf Etf (VTI)
Broadcom Stock (AVGO)
Palantir Technologies Inc Cl A Stock (PLTR)

View all positions for EverSource Wealth Advisors

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
Vanguard Group
Raffles Associates
Brian McDonald
Millennium Management
Geode Capital Management
BlackRock
Renaissance Technologies
Dauntless Investment Group
State Street Corporation
Morgan Stanley
GSA Capital Partners
Red Crane Wealth Management
Northern Trust
Eudaimonia Asset Management

View all funds holding Lineage Cell Therapeutics In